AIDS vaccine may offer hope only for some ethnic groups

BMJ 2003; 326 doi: 10.1136/bmj.326.7387.463 (Published 1 March 2003)
Cite this as: BMJ 2003;326:463.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Lynn Eaton
  1. London

    An AIDS vaccine, which has been in phase III trials for the past three years, has failed to show a significant reduction in the development of HIV among the those who were vaccinated, the manufacturer, VaxGen, has announced.

    But the vaccine has shown a significant reduction in certain ethnic groups, indicating that black and Asian volunteers may have produced higher levels of antibodies against HIV than white and Hispanic volunteers.

    The full trial results are to be …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL